Showing results (11-20 of 37) with videos related to
Sort By:
Pageof 4
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 26, 2021
Fate of the liver in the survivors of adult heart transplant for a failing Fontan circulationChristopher R Broda, Rafael Alonso-Gonzalez, Anand Ghanekar, et al.JHEP Reports : Innovation in Hepatology|February 11, 2020
Methylation signatures in peripheral blood are associated with marked age acceleration and disease progression in patients with primary sclerosing cholangitisMichael Trauner, Yevgeniy Gindin, Zhaoshi Jiang, et al.Hepatology Communications|August 3, 2023
Living donor liver transplantation can address disparities in transplant access for patients with primary sclerosing cholangitisFernanda Onofrio, Katina Zheng, Cherry Xu, et al.Journal of Crohn'S & Colitis|July 9, 2024
Inflammatory bowel disease associated with primary sclerosing cholangitis is associated with an altered gut microbiome and bile acid profileHaim Leibovitzh, Shadi Nayeri, Krzysztof Borowski, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 7, 2022
Safety and Sustained Efficacy of the Farnesoid X Receptor (FXR) Agonist Cilofexor Over a 96-Week Open-label Extension in Patients With PSCMichael Trauner, Christopher L Bowlus, Aliya Gulamhusein, et al.JHEP Reports : Innovation in Hepatology|November 25, 2022
Inflammatory conditions play a role in recurrence of PSC after liver transplantation: An international multicentre studyThijmen Visseren, Nicole S Erler, Julie K Heimbach, et al.Hepatology (Baltimore, Md.)|January 21, 2019
The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing CholangitisMichael Trauner, Aliya Gulamhusein, Bilal Hameed, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 15, 2024
Pursuing living donor liver transplantation improves outcomes of patients with autoimmune liver diseases: An intention-to-treat analysisOwen Jones, Marco P A W Claasen, Tommy Ivanics, et al.Hepatology (Baltimore, Md.)|June 10, 2022
IL-31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases and is farnesoid X receptor responsive in NASHJun Xu, Ya Wang, Mina Khoshdeli, et al.Journal of Hepatology|January 10, 2024
Single-cell, single-nucleus, and spatial transcriptomics characterization of the immunological landscape in the healthy and PSC human liverTallulah S Andrews, Diana Nakib, Catia T Perciani, et al.Pageof 4